A Population‐Based Assessment of Cancer Risk in Children With <scp>VACTERL</scp>
Cancer risk in children with VACTERL, a nonrandom co-occurrence of ≥ 3 defects (vertebral, anal, cardiac, tracheoesophogeal fistula, renal, and limb), remains unclear. We evaluated this association in a population-based study. We analyzed data from the Genetic Overlap Between Anomalies and Cancer in Kids (GOBACK) Study, a US registry linkage cohort. VACTERL was defined as the presence of ≥ 3 associated defects. Cox regression was applied to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for cancer risk before age 18 in children with VACTERL compared to children without birth defects. Kaplan-Meier analyses were used to estimate cumulative incidence of cancer in each group. Of 21,224,742 births, 2288 met VACTERL criteria; 8 developed cancer, 5 (63%) of whom were diagnosed with embryonal tumors. Children with VACTERL had a significantly increased cancer risk (HR = 3.0, 95% CI: 1.5-6.0), particularly for embryonal tumors (HR = 6.9, 95% CI: 2.9-16.5), relative to unaffected children. Cancer incidence was 421.3 (95% CI: 181.9, 830.0) per million person-years for VACTERL versus 133.4 (95% CI: 131.8-135.0) for unaffected children. Children with VACTERL may face increased cancer risk. Shared developmental or epigenetic mechanisms may underlie both conditions, highlighting efforts to identify subgroups that may benefit from targeted surveillance.
Authors
- Michael E. Scheurer (ORCID: https://orcid.org/0000-0002-8379-6088)
- A. Janitz
- S. E. Plon
- Tania A. Desrosiers (ORCID: https://orcid.org/0000-0003-1600-3700)
- Charles Shumate (ORCID: https://orcid.org/0000-0003-2884-2835)
- Barbara Luke (ORCID: https://orcid.org/0000-0002-0405-8133)
- Philip J. Lupo (ORCID: https://orcid.org/0000-0003-0978-5863)
- Alexander Renwick (ORCID: https://orcid.org/0000-0003-4026-488X)
- Jeremy M. Schraw (ORCID: https://orcid.org/0000-0002-6674-9562)
- Angela E. Scheuerle (ORCID: https://orcid.org/0000-0002-9025-3276)
- Chad Huff
- Ann Nordgren
- Ji Yun Tark
- Giorgio Tettamanti
- Andrew F. Olshan
- Rachel D. Harris
Institutions
- University of North Carolina at Chapel Hill (US)
- St. Jude Children's Research Hospital (US)
- Karolinska University Hospital (SE)
- The University of Texas MD Anderson Cancer Center (US)
- Texas Department of State Health Services (US)
- Emory University (US)
- Baylor College of Medicine (US)
- Great Ormond Street Hospital (GB)
- Sahlgrenska University Hospital (SE)
- Karolinska Institutet (SE)
- Aflac (United States) (US)
- Children's Healthcare of Atlanta (US)
- University College London (GB)
- University of Oklahoma Health Sciences Center (US)
- Rice University (US)
- The University of Texas Southwestern Medical Center (US)
- Michigan State University (US)
- University of Gothenburg (SE)
Publication Details
- Journal
- American Journal of Medical Genetics Part A
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1002/ajmga.70031
- Primary Topic
- Esophageal and GI Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- Rally Foundation
- Cancer Prevention and Research Institute of Texas
- National Cancer Institute
- National Institute of Child Health and Human Development